The activity is largely driven by routine tax settlements following equity vesting, which is common and not necessarily indicative of negative sentiment. However, the size of the open-market sales by two executives warrants monitoring for potential follow-up transactions or commentary around corporate performance.
Price Chart
Executive Summary
Multiple executives at ANI Pharmaceuticals, including the CEO, CFO, and other senior leaders, engaged in tax-related share withholdings and open-market sales over the past week. The total value of transactions exceeds $2.6 million, with $913,092 in open-market sales and $1.7 million in tax withholding dispositions.
Key Financial Metrics
Key Facts
- CEO Nikhil Lalwani surrendered 17,060 shares ($1.26M) for tax withholding.
- CFO Stephen Carey and other SVPs also surrendered shares for tax purposes, totaling $1.7M across four executives.
- Two executives, Christopher Mutz and Krista Davis, conducted open-market sales totaling $913,092.
- All open-market sales occurred at prices between $74.13 and $75.00.
- No purchases or positive transactions were reported.
Financial Impact
$2.6M total insider activity over 7 days, including $913K in open-market sales and $1.7M in tax-related share dispositions
Risk Factors
- Perception of insider selling could weigh on investor sentiment, especially given the high dollar volume.
- Absence of any insider buying may signal lack of near-term confidence, though not conclusive.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (8 trades, 7d window) | cluster-ANIP-1773173388948 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $72.11 $77.91 | ▲ +8.04% | ▲ +7.23% | $71.97 (−0.19%) |
Sep 1, 2026 4w ago | Insider Cluster | $73.06 $71.46 | ▼ −2.19% | ▼ −1.23% | $71.97 (−1.49%) |
Aug 24, 2026 5w ago | 8-K | $74.17 $73.25 | ▼ −1.24% | ▼ −1.71% | $71.97 (−2.97%) |
Aug 13, 2026 7w ago | Insider Cluster | $74.77 $77.32 | ▲ +3.41% | ▲ +5.37% | $71.97 (−3.74%) |
Aug 7, 2026 8w ago | 8-K | $78.25 $76.54 | ▼ −2.19% | ▼ −2.58% | $71.97 (−8.03%) |
Jul 16, 2026 11w ago | Court Ruling | $81.92 $78.53 | ▼ −4.14% | ▼ −2.47% | $71.97 (−12.15%) |
Jul 13, 2026 11w ago | Press Release | $81.08 $79.20 | ▼ −2.32% | ▼ −1.53% | $71.97 (−11.24%) |
Jun 15, 2026 15w ago | Insider Cluster | $83.00 $82.94 | ▼ −0.07% | ▲ +2.16% | $71.97 (−13.29%) |
Jun 11, 2026 16w ago | Insider Cluster | $81.65 $80.52 | ▼ −1.38% | ▼ −1.82% | $71.97 (−11.86%) |
May 21, 2026 19w ago | 8-K | $82.72 $76.71 | ▼ −7.27% | ▼ −8.92% | $71.97 (−13.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access